SomaLogic Scores One-Time, $21.2M Licensing Royalty in Q3, Raises FY 2022 Revenue Guidance
The Boulder, Colorado-based proteomics assay maker beat Wall Street estimates on the top and bottom lines in Q3, driven by higher product revenues.
Genuity Science, Ionis Pharmaceuticals Partner on Antisense Therapy Development
Genuity Science, formerly known as WuXi NextCode, will receive a combination of upfront, development milestone, and product royalty payments under the deal.
Tempus, Genmab Collaborate on Cancer Biomarker Discovery
Tempus is eligible for milestone payments and royalties for any oncology therapeutics Genmab might develop based on their joint research projects.
Interpace Dx Reaches Deal to Restructure Debt
As part of the deal with an institutional investor, Interpace's royalty and milestone obligations will also be terminated.
Life Technologies last week reported a 1 percent decrease in revenues for its Genetic Analysis unit and flat sales in its Applied Sciences unit in the third quarter, contributing to a 2 percent decline in overall company revenues year over year.
Feb 9, 2012
Feb 9, 2012
Oct 20, 2011
Apr 28, 2011
Jan 14, 2010